241 results
Page 6 of 13
8-K
EX-99.1
nivgsrc8uzrz7lv
2 Apr 20
Insmed Appoints Carol A. Schafer to its Board of Directors
8:01am
8-K
EX-99.1
978qb2ciknq9ndt9
16 Mar 20
Insmed Provides Business Update
4:10pm
8-K
EX-99.1
dywt6ivnvd13 9qfh
25 Feb 20
Investor Presentation February 2020 Not for promotional use
11:11am
8-K
EX-99.1
qcbz 34s0rkmwv
25 Feb 20
Insmed Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
7:31am
8-K
EX-99.1
f2s7cq1k j5
3 Feb 20
Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchiectasis
7:49am
8-K
EX-99.1
9gw0u
30 Jan 20
Insmed Appoints Sara Bonstein as Chief Financial Officer
7:59am
8-K
67yuty
13 Jan 20
Investor Presentation January 2020 Not for promotional use
8:00am
8-K
EX-99.1
nqkmfi7t
13 Jan 20
Investor Presentation January 2020 Not for promotional use
8:00am
8-K
EX-99.1
u9aqkdjl dpe0to
18 Nov 19
Insmed Appoints Dr. Clarissa Desjardins to its Board of Directors and Names Roger Adsett Chief Operating Officer
4:19pm
8-K
EX-99.1
ms5nas lu
30 Oct 19
Insmed Reports Third Quarter 2019 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
9knyu
1 Aug 19
Insmed Reports Second Quarter 2019 Financial Results and Provides Business Update
7:31am
8-K
EX-1.1
w8cch60n
24 May 19
Insmed Announces Proposed Public Offering of Common Stock
6:01am
8-K
EX-99.1
qugrljedphh
7 May 19
Insmed Reports First Quarter 2019 Financial Results and Provides Business Update
7:30am
8-K
EX-10.1
u99ohq
7 May 19
Insmed Reports First Quarter 2019 Financial Results and Provides Business Update
7:30am
8-K
EX-99.1
6p1rf
8 Apr 19
Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch
9:08am
8-K
EX-99.1
2ayiq3faqas5v em3
22 Feb 19
Insmed Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
7:31am